Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The gut microbiome and antipsychotic treatment response
Mary V. Seeman
Behavioural Brain Research (2020) Vol. 396, pp. 112886-112886
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota
Anna E. Lindell, Maria Zimmermann‐Kogadeeva, Kiran Raosaheb Patil
Nature Reviews Microbiology (2022) Vol. 20, Iss. 7, pp. 431-443
Open Access | Times Cited: 134
Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives
Evgeny A. Ermakov, Mark M. Melamud, Valentina N. Buneva, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 95
The gut microbiome and mental health: advances in research and emerging priorities
Andrew Shoubridge, Jocelyn M. Choo, Alyce M. Martin, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 1908-1919
Closed Access | Times Cited: 81
Schizophrenia: The new etiological synthesis
Markus J. Rantala, Severi Luoto, Javier I. Borráz-León, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 142, pp. 104894-104894
Open Access | Times Cited: 47
Probiotics, Live Biotherapeutic Products (LBPs), and Gut-Brain Axis Related Psychological Conditions: Implications for Research and Dietetics
Duygu Ağagündüz, Elif Çelik, Özge Cemali, et al.
Probiotics and Antimicrobial Proteins (2023) Vol. 15, Iss. 4, pp. 1014-1031
Closed Access | Times Cited: 28
The Underlying Neurobiological Mechanisms of Psychosis: Focus on Neurotransmission Dysregulation, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction
Neha S. Rawani, Allen W. Chan, Serdar Dursun, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 709-709
Open Access | Times Cited: 11
Mood Disorders: The Gut Bacteriome and Beyond
Amelia J. McGuinness, Amy Loughman, Jane A. Foster, et al.
Biological Psychiatry (2023) Vol. 95, Iss. 4, pp. 319-328
Open Access | Times Cited: 17
Nutrition, nutritional deficiencies, and schizophrenia: An association worthy of constant reassessment
Olakunle J. Onaolapo, Adejoke Y. Onaolapo
World Journal of Clinical Cases (2021) Vol. 9, Iss. 28, pp. 8295-8311
Open Access | Times Cited: 37
Involvement of Gut Microbiota in Schizophrenia and Treatment Resistance to Antipsychotics
Mirko Manchia, Andrea Fontana, Concetta Panebianco, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 875-875
Open Access | Times Cited: 34
Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia
Benneth Ben‐Azu, Elisabetta C. del Re, Jared VanderZwaag, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
Current and emerging long-acting antipsychotics for the treatment of schizophrenia
Renato de Filippis, Pasquale De Fazio, Raffaele Gaetano, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 7, pp. 771-790
Closed Access | Times Cited: 32
Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics
Nicole Moschny, Gudrun Hefner, R. Grohmann, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 514-514
Open Access | Times Cited: 32
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia
Martina Garofalo, Giuseppe De Simone, Zoraide Motta, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 4
Gut microbiome characteristics in individuals across different stages of schizophrenia spectrum disorders: A systematic review and meta-analysis
Li Kong, Xingsong Wang, Guanlin Chen, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106167-106167
Closed Access
The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence
Alexis E. Cullen, Javier Labad, Dominic Oliver, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 3, pp. 350-377
Open Access | Times Cited: 10
The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats
Srinivas Kamath, Alexander Hunter, Kate Collins, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 22, pp. 4531-4545
Open Access | Times Cited: 3
Serum Metabolic Profile in Schizophrenia Patients With Antipsychotic-Induced Constipation and Its relationship With Gut Microbiome
Nousayhah Amdanee, Miaomiao Shao, Xiuxiu Hu, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 3, pp. 646-658
Open Access | Times Cited: 9
Altered levels of fecal short-chain fatty acids are associated with subclinical inflammation and worse cognitive performance in patients with schizophrenia
Krzysztof Kowalski, Bogumiła Szponar, Patrycja Bochen, et al.
Journal of Psychiatric Research (2023) Vol. 165, pp. 298-304
Open Access | Times Cited: 8
The atypical antipsychotic lurasidone positively modulates the gut microbiota in rats: A comparative study to olanzapine
Srinivas Kamath, Alexander Hunter, Kate Collins, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
IUPHAR Themed Review: The Gut Microbiome in Schizophrenia
Srinivas Kamath, Elysia Sokolenko, Kate Collins, et al.
Pharmacological Research (2024), pp. 107561-107561
Open Access | Times Cited: 2
Novel ketamine and zinc treatment for anorexia nervosa and the potential beneficial interactions with the gut microbiome
Rosiel Elwyn, Jules Mitchell, Michael Kohn, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 148, pp. 105122-105122
Closed Access | Times Cited: 5
What is the significance of the impact of antipsychotics on the gut microbiome?
Mary V. Seeman
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 3, pp. 125-127
Closed Access | Times Cited: 5
Probiotics and Fecal Microbiota Transplantation in Major Depression: Doxa or Episteme?
Alper Evrensel
Advances in experimental medicine and biology (2024), pp. 67-83
Closed Access | Times Cited: 1
Nutrition and schizophrenia: associations worthy of continued revaluation
Mimi Tang, Tingyu Zhao, Ting Liu, et al.
Nutritional Neuroscience (2023) Vol. 27, Iss. 6, pp. 528-546
Closed Access | Times Cited: 3
Comparative analysis of microbiome indicators in patients with mental disorders and in healthy volunteers
I. Yu. Torshin, О. А. Громова, Н. П. Ванчакова, et al.
Experimental and Clinical Gastroenterology (2023), Iss. 8, pp. 92-105
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top